Methods of Pancreatic Stump Closure for Distal Pancreatectomy

Stapler Versus Stapler Combined With Electrocautery for Pancreatic Transection and Stump Closure for Distal Pancreatectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06424431

Enrollment

487

Registered

2024-05-22

Start date

2019-01-01

Completion date

2024-04-01

Last updated

2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatectomy

Brief summary

Detailed description

The aim of this study is to conduct a retrospective analysis of patients who underwent distal pancreatectomy in our hospital, aiming to evaluate the safety and feasibility of two methods for closure of the pancreatic remnant: simple closure with a closure device and closure combined with electrocoagulation. This study aims to determine which method is safer and more feasible, with the potential to reduce postoperative complications, improve outcomes, facilitate better patient recovery, and thereby provide better guidance for clinical practice.

Interventions

PROCEDUREstapler combined with electrocautery

Closure with a closure device combined with electrocoagulation for pancreatic stump closure in distal pancreatectomy

PROCEDUREsimple closure with a closure device

Simple closure with a closure device for pancreatic stump closure in distal pancreatectomy

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients who underwent distal pancreatectomy performed by Director Jin Gang's team at Changhai Hospital affiliated with Naval Medical University between January 2019 and January 2023. * Patients who underwent closure of the pancreatic remnant using either simple closure or closure combined with electrocoagulation during surgery.

Exclusion criteria

* Patients undergoing surgeries by other primary clinical teams during the same period. * Patients undergoing closure of the pancreatic remnant using methods other than those mentioned. * Patients who violate the requirements of the study protocol. * Patients with incomplete data collection in the hospital's diagnostic and treatment system.

Design outcomes

Primary

Measure	Time frame	Description
Postoperative pancreatic fistula	perioperatively	Postoperative pancreatic fistula

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026